These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1248113)

  • 41. Isolation and mass spectrometric identification of gitoxin metabolites excreted in bile.
    Kadima LN; Lhoest G; Lesne M
    Eur J Drug Metab Pharmacokinet; 1982; 7(2):111-7. PubMed ID: 7117294
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on the pharmacokinetics and the metabolism of gitoxin in the guinea-pig: I. Disposition kinetics following an i.v. bolus of 3H-gitoxin.
    Kadima LN; Lesne M
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):20-41. PubMed ID: 7406600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism and excretion in bile of SC4453, a new semi-synthetic derivative of digoxin following an i.v. bolus injection in the guinea-pig.
    Randimbivololona F; Lesne M
    J Pharmacol; 1984; 15(1):53-64. PubMed ID: 6717027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone metabolites in dog bile.
    Yamamoto Y; Osawa Y; Kirdani RY; Sandberg AA
    Steroids; 1978 Feb; 31(2):233-47. PubMed ID: 663966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of digoxin after oral and intrajejunal administration.
    Magnusson JO
    Br J Clin Pharmacol; 1983 Dec; 16(6):741-2. PubMed ID: 6661363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific and sensitive assays for digoxin in plasma, urine and heart tissue.
    Morais JA; Zlotecki RA; Sakmar E; Stetson PL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):285-98. PubMed ID: 7221184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.
    Magnusson JO; Bergdahl B; Bogentoft C; Gustafsson S; Jonsson UE
    Eur J Clin Pharmacol; 1984; 27(2):197-202. PubMed ID: 6499898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H.
    Harrison CE; Brandenburg RO; Ongley PA; Orvis AL; Owen CA
    J Lab Clin Med; 1966 May; 67(5):764-77. PubMed ID: 5946035
    [No Abstract]   [Full Text] [Related]  

  • 49. Digoxin inactivation by the gut flora in infancy and childhood.
    Linday L; Dobkin JF; Wang TC; Butler VP; Saha JR; Lindenbaum J
    Pediatrics; 1987 Apr; 79(4):544-8. PubMed ID: 3822671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary excretion of digoxin and its metabolites in hyperacidic patients and in patients during coronary care.
    Magnusson JO; Bergdahl B; Gustafsson S
    Arzneimittelforschung; 1984; 34(1):87-9. PubMed ID: 6538426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Renal and extracorporeal elimination of digoxin and its methylated and acetylated derivatives].
    Risler T
    Fortschr Med; 1983 Dec; 101(47-48):2185-8. PubMed ID: 6671635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the pharmacokinetics and the metabolism of gitoxin in the guinea-pig: II. the enteral absorption and the enterohepatic recirculation.
    Kadima LN; Lesne M
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):4-14. PubMed ID: 7138145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of acetylcholine and atropine on the bile flow and biliary excretion of digoxin in the isolated perfused rat liver.
    Nevasaari K; Alakare B; Kärki NT
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):165-9. PubMed ID: 995213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of digoxin and absorption site.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE
    Br J Clin Pharmacol; 1982 Aug; 14(2):284-5. PubMed ID: 7104181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolism of 3H-digoxin and some acetyl-digoxins: time-dependent formation of hydrophilic metabolites after oral application in man.
    Dwenger A; Haberland G
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):102-4. PubMed ID: 4253058
    [No Abstract]   [Full Text] [Related]  

  • 56. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies of the excretion of digoxin through urine in the human].
    Weiss D; Meyer-Elmen E; Ruiz-Torres A
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():202-5. PubMed ID: 5736264
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of cholestyramine on absorption of 3H digoxin in rats.
    Thompson WG
    Am J Dig Dis; 1973 Oct; 18(10):851-6. PubMed ID: 4742358
    [No Abstract]   [Full Text] [Related]  

  • 59. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross reactivity of the EMIT digoxin assay with digoxin metabolites, and validation of the method for measurement of urinary digoxin.
    Linday L; Drayer DE
    Clin Chem; 1983 Jan; 29(1):175-7. PubMed ID: 6336678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.